The “Diagnosis, treatment and prevention of severe acute respiratory syndrome coronavirus 2 infection in children: experts’ consensus statement (Fourth Edition)” (43) suggests that IFN-α inhalation can be used for children with pneumonia and other lower respiratory tract infections. This evidence concerns the gene IFNA1 and susceptibility to pneumonia measurement.